52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

No DR Events are available.

No DR Events are available.

Data provided by Thomson Reuters

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
Mar 31, 2025 TBA TBA
Sep 30, 2024 Dec 12, 2024 0.2885
Mar 28, 2024 Jul 08, 2024 0.2580
Sep 29, 2023 Dec 11, 2023 0.2822

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Nikko Asset Management Co., Ltd. 87,400,834
Capital Research & Management Co. (Global Investors) 13,162,513
Parametric Portfolio Associates LLC 5,137,715
TOP MUTUAL FUND HOLDERS POSITION
American Mutual Fund 12,888,047
First Trust Value Line Dividend Index Fund 2,719,214
VanEck Pharmaceutical ETF 2,017,774

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol TAK
CUSIP 874060205
DR Venue New York Stock Exchange
DR ISIN US8740602052
Ratio DR:ORD 2:1
Underlying ISIN JP3463000004
Underlying SEDOL 6870445
Country Japan
Effective Date Dec 24, 2018
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
Takeda Pharmaceutical is a biopharmaceutical company with an innovative portfolio, engaged primarily in the research, development, production and marketing of pharmaceutical products. The Company has a geographically diversified global business and provides its prescription drugs in Japan and overseas. The Company's principal pharmaceuticals are antidiabetic, antihypertensive medicine, drugs for multiple myeloma and mantle cell lymphoma, medicine for reflux esophagitis, and hyperuricemia treatment. The Company focuses its R&D activities on four core therapeutic areas of oncology, rare genetics and hemotology, neuroscience, gastroenterology, plasma-derived therapies and vaccines.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0500
Cancellation up to $0.0500
Cash Distribution up to $0.0500
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0500
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 15.29 52,964,160 2,522,103
Mar.25 14.87 34,813,281 1,657,775
Feb.25 14.41 28,552,488 1,502,763

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE